Actemra® During Pregnancy?
Rheumatologists need more information on how rheumatoid arthritis and Actemra® (tocilizumab) affect a pregnancy. We provide free up-to-date, evidence-based information on the use of Actemra® in pregnancy. We also conduct a nationally recognized pregnancy registry for women with RA, including those who used Actemra® while pregnant.
RA & Actemra® Pregnancy Registry
We are enrolling women with RA who have and those who have not used Actemra® in a current or recent pregnancy. Please consider referring your patients. The registry is strictly observational and open to women in the US and Canada; participants self-enroll and are not asked to take or change any medications, travel, or make any changes to current health routines.
Participants Can Expect
- 1-3 phone interviews during pregnancy and at least 1 post-partum phone interview
- Request of medical records for their pregnancy and for their baby
- Babies may be eligible to receive a FREE specialized non-invasive pediatric exam with a study doctor.
Free Resources
MotherToBaby is dedicated to providing no-cost evidence-based information to mothers, healthcare professionals and the general public about medications, maternal medical conditions, and other exposures during pregnancy and while breastfeeding. Our information service is a recommended resource by the Centers for Disease Control and Prevention (CDC) and the Food & Drug Administration’s (FDA) Office of Women’s Health.
Visit MotherToBaby.org to access our free resources, including:
- Our no-cost teratogen information service
- Patient-friendly Fact Sheets on topics such as rheumatoid arthritis, tocilizumab, methotrexate and prednisone (among others), available in English or Spanish
- Patient Brochures